INSERM U1149, Centre de Recherche sur l'Inflammation, Paris, France.
CNRS ERL8252, Paris, France.
Sci Signal. 2018 Jul 3;11(537):eaan4350. doi: 10.1126/scisignal.aan4350.
Soluble -ethylmaleimide-sensitive factor attachment protein receptor (SNARE) family proteins mediate membrane fusion critical for vesicular transport and cellular secretion. Mast cells rely on SNARE-mediated membrane fusion for degranulation stimulated by crosslinking of immunoglobulin E (IgE) bound to the Fcε receptor (FcεRI). We investigated the mechanisms downstream of receptor activation that control degranulation. We found that the SNARE binding protein tomosyn-1 (also known as STXBP5) inhibited FcεRI-stimulated degranulation of mast cells. After mast cell activation, tomosyn-1 was phosphorylated on serine and threonine residues, dissociated from the SNARE protein syntaxin 4 (STX4), and associated with STX3. We identified PKCδ as the major kinase required for tomosyn-1 threonine phosphorylation and for regulation of the interaction with STXs. Incubation with high IgE concentrations increased tomosyn-1 abundance in cultured mast cells. Similarly, in basophils from allergic patients with high amounts of serum IgE, the abundance of tomosyn-1 was increased as compared to that in patients with normal IgE concentrations. Our findings identified tomosyn-1 as an inhibitor of mast cell degranulation that required PKCδ to switch its interaction with STX partners during fusion. We suggest that the IgE-mediated increase in tomosyn-1 abundance in allergic patients may represent a counterregulatory mechanism to limit disease development.
可溶性 - 乙基maleimide 敏感因子附着蛋白受体(SNARE)家族蛋白介导膜融合,对于囊泡运输和细胞分泌至关重要。肥大细胞依赖 SNARE 介导的膜融合来进行脱粒,这是由与 Fcε受体(FcεRI)结合的免疫球蛋白 E(IgE)交联刺激的。我们研究了控制脱粒的受体激活下游机制。我们发现 SNARE 结合蛋白 tomosyn-1(也称为 STXBP5)抑制了肥大细胞受 FcεRI 刺激的脱粒。肥大细胞活化后,tomosyn-1 丝氨酸和苏氨酸残基被磷酸化,与 SNARE 蛋白 syntaxin 4(STX4)解离,并与 STX3 结合。我们确定 PKCδ 是 tomosyn-1 苏氨酸磷酸化和调节与 STXs 相互作用所必需的主要激酶。高 IgE 浓度孵育会增加培养的肥大细胞中 tomosyn-1 的丰度。同样,在 IgE 浓度正常的过敏患者的嗜碱性粒细胞中,与 IgE 浓度正常的患者相比,tomosyn-1 的丰度增加。我们的发现确定了 tomosyn-1 是肥大细胞脱粒的抑制剂,它需要 PKCδ 在融合过程中改变其与 STX 伙伴的相互作用。我们认为,过敏患者中 IgE 介导的 tomosyn-1 丰度增加可能代表一种代偿性机制,以限制疾病的发展。